In this issue:
Predicting cervical cancer elimination for Aboriginal and Torres Strait Islander women
Weekly versus tri-weekly cisplatin
Improving survival prediction for LACC
Examination of pembrolizumab plus olaparib
The efficacy and safety of tisotumab vedotin
Triage of HPV-positive women using DS and HPV genotyping
Molecular drivers of HPV-negative and HPV-positive cervical cancer
ctDNA-based mutation profiling
Feasibility, safety and efficacy of autologous subcutaneous ovarian grafting
Comparison between adjuvant strategies
Please login below to download this issue (PDF)